Translating Extinction Research to Improve Pharmacotherapy for Tobacco Dependence
Translating Extinction Research to Improve Pharmacotherapy for Tobacco Dependence: Intervention Development and Feasibility Trial
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
A EARLY_PHASE1 clinical study on Smoking Cessation and Tobacco Dependence, this trial is completed. The trial is conducted by H. Lee Moffitt Cancer Center and Research Institute and has accumulated 12 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed EARLY_PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Completed EARLY_PHASE1
-
Dec 2020 — Jan 2021 [monthly]
Completed EARLY_PHASE1
-
Jul 2020 — Dec 2020 [monthly]
Completed EARLY_PHASE1
▶ Show 7 earlier versions
-
Feb 2020 — Jul 2020 [monthly]
Completed EARLY_PHASE1
-
Sep 2019 — Feb 2020 [monthly]
Completed EARLY_PHASE1
Status: Active Not Recruiting → Completed
-
Aug 2019 — Sep 2019 [monthly]
Active Not Recruiting EARLY_PHASE1
-
Jun 2018 — Aug 2019 [monthly]
Active Not Recruiting EARLY_PHASE1
-
Jun 2017 — Jun 2018 [monthly]
Active Not Recruiting EARLY_PHASE1
Phase: NA → EARLY_PHASE1
-
Feb 2017 — Jun 2017 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting NA
First recorded
Jul 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- H. Lee Moffitt Cancer Center and Research Institute
- James and Esther King Biomedical Research Program
- Pfizer
For direct contact, visit the study record on ClinicalTrials.gov .